Paper · 39680919

Engineering Phages to Fight Multidrug-Resistant Bacteria.

Peng H and 2 others. Chem Rev, 2025. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Engineering Phages to Fight Multidrug-Resistant Bacteria. Papers, record 39680919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39680919

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Engineering Phages to Fight Multidrug-Resistant Bacteria.; PubMed
Journal: Chem Rev; PubMed
Year: 2025; PubMed
Publication types: Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/39680919/; PubMed
DOI: https://doi.org/10.1021/acs.chemrev.4c00681; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC11758799/; PubMed
The journal: https://conductscience.org/library/journal-index/2985134R; PubMed
Citations, by iCite: 69; iCite
Relative citation ratio, by iCite: 21.75, provisional; iCite
Revised in PubMed: 2026-08-11; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Peng H	Huan	https://orcid.org/0000-0001-6799-946X
2	Chen IA	Irene A	https://orcid.org/0000-0001-6040-7927
3	Qimron U	Udi

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Bacteriophages	Major topic
Drug Resistance, Multiple, Bacterial	Major topic
Bacteria	Major topic
Genetic Engineering	Major topic
Humans
Anti-Bacterial Agents
Phage Therapy
Bacterial Infections

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
R35 GM148249	NIGMS NIH HHS	United States	R35GM148249	PubMed and NIH

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References366

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	22,575,828	Stepwise molecular display utilizing icosahedral and helical complexes of phage coat and decoration proteins in the development of robust nanoscale display vehicles.	Biomaterials	2012	https://conductscience.org/library/papers/22575828	PubMed
2	27,672,148	CRISPR-Cas: biology, mechanisms and relevance.	Philos Trans R Soc Lond B Biol Sci	2016	https://conductscience.org/library/papers/27672148	PubMed
3	14,227,038	THE INITIAL STEPS IN INFECTION WITH COLIPHAGE M13.	Virology	1964	https://conductscience.org/library/papers/14227038	PubMed
4	33,304,748	Bacteria Detection: From Powerful SERS to Its Advanced Compatible Techniques.	Adv Sci (Weinh)	2020	https://conductscience.org/library/papers/33304748	PubMed
5	32,475,408	Selective protein N-terminal labeling with N-hydroxysuccinimide esters.	Methods Enzymol	2020	https://conductscience.org/library/papers/32475408	PubMed
6	23,917,638	Rapid (<5 min) identification of pathogen in human blood by electrokinetic concentration and surface-enhanced Raman spectroscopy.	Sci Rep	2013	https://conductscience.org/library/papers/23917638	PubMed
7	31,147,612	The next generation of CRISPR-Cas technologies and applications.	Nat Rev Mol Cell Biol	2019	https://conductscience.org/library/papers/31147612	PubMed
8	19,835,886	Structure of the small outer capsid protein, Soc: a clamp for stabilizing capsids of T4-like phages.	J Mol Biol	2010	https://conductscience.org/library/papers/19835886	PubMed
9	35,434,949	Photocatalytic Quantum Dot-Armed Bacteriophage for Combating Drug-Resistant Bacterial Infection.	Adv Sci (Weinh)	2022	https://conductscience.org/library/papers/35434949	PubMed
10	26,028,539	A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.	Mol Cell	2015	https://conductscience.org/library/papers/26028539	PubMed

1 to 10 of 366

See all 366 references

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMID	Title	Journal	Year	In Papers	Source
42,979,754	Coupling metabolic enhancement to plasmid spread enables programmable antimicrobial control.	Nucleic Acids Res	2026	https://conductscience.org/library/papers/42979754	PubMed
42,964,817	Recognition-decision-execution: a new design principle for intelligent antimicrobial systems.	Front Microbiol	2026	https://conductscience.org/library/papers/42964817	PubMed
42,962,024	A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria.	Sci Adv	2026	https://conductscience.org/library/papers/42962024	PubMed
42,840,453	Phage therapy for multidrug-resistant pulmonary infections: bridging precision matching, lung delivery, host immunity, and clinical translation.	Front Cell Infect Microbiol	2026	https://conductscience.org/library/papers/42840453	PubMed
42,797,510	Phage Genomics and Bioinformatics in Therapeutic Development: Evidence Limits, Validation Gates, and Translational Decision-Making.	Pharmaceuticals (Basel)	2026	https://conductscience.org/library/papers/42797510	PubMed
42,796,746	A Biological Approach to Antimicrobial Resistance in New and Old Bacterial Pathogens.	Pathogens	2026	https://conductscience.org/library/papers/42796746	PubMed
42,795,594	Innovative Applications of Artificial Intelligence in Bacteriophage Research: A New Chapter in Future Medicine.	Microorganisms	2026	https://conductscience.org/library/papers/42795594	PubMed
42,694,502	Next-generation anti-infective drugs in the post-antibiotic era: focusing on anti-virulence agents targeting the bacterial quorum sensing system.	Front Cell Infect Microbiol	2026	https://conductscience.org/library/papers/42694502	PubMed
42,663,457	Antibiotic-induced cellular enlargement drives phage synergy and resensitizes carbapenem-resistant Acinetobacter baumannii.	Microbiol Spectr	2026	https://conductscience.org/library/papers/42663457	PubMed
42,653,108	Phage Therapy Enhanced by Using Engineered Bacteriophages: A Powerful Antibacterial Tool to Address the Dilemma Posed by Multidrug-Resistant Bacterial Infections.	Int J Mol Sci	2026	https://conductscience.org/library/papers/42653108	PubMed

1 to 10 of 59

See all 59 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39680919

GET https://conductscience.org/api/papers/v1/39680919/references?page=2

API reference For AI assistants